You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BARSTATIN 100 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Barstatin 100, and what generic alternatives are available?

Barstatin 100 is a drug marketed by Barlan and is included in one NDA.

The generic ingredient in BARSTATIN 100 is nystatin. There are eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the nystatin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Barstatin 100

A generic version of BARSTATIN 100 was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BARSTATIN 100?
  • What are the global sales for BARSTATIN 100?
  • What is Average Wholesale Price for BARSTATIN 100?
Summary for BARSTATIN 100
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 21
DailyMed Link:BARSTATIN 100 at DailyMed
Drug patent expirations by year for BARSTATIN 100

US Patents and Regulatory Information for BARSTATIN 100

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barlan BARSTATIN 100 nystatin POWDER;ORAL 062489-001 Apr 27, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.